Stocks and InvestingStocks and Investing
Fri, December 1, 2023
Thu, November 30, 2023
Wed, November 29, 2023
Tue, November 28, 2023

Brian Abrahams Maintained (XENE) at Buy with Increased Target to $56 on, Nov 28th, 2023


Published on 2024-10-28 07:45:34 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Buy with Increased Target from $51 to $56 on, Nov 28th, 2023.

Brian has made no other calls on XENE in the last 4 months.



There are 4 other peers that have a rating on XENE. Out of the 4 peers that are also analyzing XENE, 0 agree with Brian's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Brian


  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $46 on, Thursday, November 9th, 2023
  • Josh Schimmer of "Cantor Fitzgerald" Initiated at Buy on, Tuesday, October 24th, 2023
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $58 on, Tuesday, August 22nd, 2023
  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $50 on, Thursday, August 10th, 2023